Written Exposure Therapy for Suicide Prevention
This study is testing a new type of therapy called Written Exposure Therapy for Suicide Prevention (WET-SP) to help military service members who have been admitted to the hospital for suicidal thoughts or behaviors. WET-SP involves five sessions where you write about a stressful experience. The study will compare WET-SP to usual care (TAU), which includes psychiatric stabilization, medication management, and group therapy. Researchers want to see if WET-SP can reduce suicidal thoughts over 30 weeks. You might be able to join if you are an active duty military service member, veteran, or beneficiary admitted to Carl R. Darnall Army Medical Center for suicidal thoughts, a suicide plan, or a suicide attempt, and have elevated levels of suicidal ideation (thoughts of suicide). The current recruitment status is unclear.
- Study design
- This interventional study plans to enroll 160 participants. It compares two approaches: WET-SP and usual care (TAU).
- What's involved
- If you are in the WET-SP group, you will have five therapy sessions; the first lasts about one hour, and the others are about 40 minutes each, including a 30-minute writing exercise. If you are in the TAU group, you will receive daily care including psychiatric stabilization, nurse case management, medication management, and psychoeducation groups.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your suicidal ideation will be measured at 10 weeks, 20 weeks, and 30 weeks after starting the study.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Written Exposure Therapy for Suicide Prevention
At a glance
Conditions
NCT05878795
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
University of Texas Health Center San Antonio
San Antonio, Texasstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Brian P Marx, PhD · PRINCIPAL_INVESTIGATOR · Dept of Psychiatry, Chobanian & Avedisian BU School of Medicine and VA Boston Healthcare System
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change in Suicidal ideation (SI)Baseline, 10 weeks
Measured by the Depressive Symptom Index-Suicidality Subscale (DSI-SS) which is a four-item self-report focusing on frequency and intensity of suicidal thoughts and urges during the past 2 weeks. Each item is scored on a 4-point Likert scale ranging from 0 to 3. Total scores can range from 0 to 12, with higher scores representing increased severity of suicidal ideation.
- SI at 20 weeks20 weeks
Measured by the Depressive Symptom Index-Suicidality Subscale (DSI-SS) which is a four-item self-report focusing on frequency and intensity of suicidal thoughts and urges during the past 2 weeks. Each item is scored on a 4-point Likert scale ranging from 0 to 3. Total scores can range from 0 to 12, with higher scores representing increased severity of suicidal ideation.
- SI at 30 weeks30 weeks
Measured by the Depressive Symptom Index-Suicidality Subscale (DSI-SS) which is a four-item self-report focusing on frequency and intensity of suicidal thoughts and urges during the past 2 weeks. Each item is scored on a 4-point Likert scale ranging from 0 to 3. Total scores can range from 0 to 12, with higher scores representing increased severity of suicidal ideation.